Coherus Biosciences, Inc.
CHRS
Revenue
123.86M
▲12.17M▲10.90%
3 Months ChangeAssets
674.86M
▼-88.69M▼-11.62%
3 Months ChangeLiabilities
758.96M
▼-86.43M▼-10.22%
3 Months ChangeFree Cash Flow
-68.88M
▼-14.22M▼-26.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-13
Form 8-K
ID: 0001558370-24-012783
2024-08-08
Form 10-Q
ID: 0001558370-24-011629
2024-08-08
Form 8-K
ID: 0001558370-24-011618
2024-07-02
Form 8-K
ID: 0001558370-24-009650
2024-06-27
Form 8-K
ID: 0001558370-24-009526
2024-06-05
Form 8-K
ID: 0001558370-24-008918
2024-06-04
Form 8-K
ID: 0001558370-24-008898
2024-05-09
Form 10-Q
ID: 0001558370-24-007641
2024-05-09
Form 8-K
ID: 0001558370-24-007622
2024-05-09
Form 8-K
ID: 0001558370-24-007468